We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating Ureteral Length Using Computed Tomography (CT) (URO-Y-2)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01542593
First Posted: March 2, 2012
Last Update Posted: April 30, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Yuval Freifeld, Carmel Medical Center
  Purpose

Proper selection of ureteral stent length might help in reducing comorbidities associated with ureteral stenting, currently there is no standardized way of measuring ureteral length.

Measurement of ureteral length according to Computed Tomography (CT) scan might provide useful information when selecting the length of a ureteral stent. Our aim in this study is to compare ureteral measurements using CT scan and measurement of actual ureteral length measured during ureteral stenting.


Condition Intervention
Ureteral Calculi Hydronephrosis Ureteral Obstruction Device: Ureteral catheterization - Cook Urological Inc. open end ureteral catheter 5FR

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Evaluation of Ureteral Length Measurement by Computed Tomography (CT) to Actual Ureteral Length Measured by Ureteral Catheterization

Resource links provided by NLM:


Further study details as provided by Yuval Freifeld, Carmel Medical Center:

Primary Outcome Measures:
  • Agreement between measurement of ureteral length (Centimeters) measured by CT and by ureteral catheterization [ Time Frame: 1 year ]

Enrollment: 53
Study Start Date: February 2012
Study Completion Date: March 2015
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Ureteral catheterization

During a planned procedure involving ureteroscopy or ureteral stenting, ureteral catheterization will be performed for the purpose of measuring exact ureteral length.

Measurement results will be compared to measurements performed on CT scan (obtained before surgery).

Device: Ureteral catheterization - Cook Urological Inc. open end ureteral catheter 5FR

During a planned procedure involving ureteroscopy or ureteral stenting, after retrograde pyelography and insertion of a safety wire, ureteral catheterization will be performed using Cook Urological Inc. open end ureteral catheter 5FR for the purpose of measuring exact ureteral length.

Measurement results will be compared to measurements performed on CT scan (obtained before surgery).

Other Names:
  • Cook Urological Inc. open end ureteral catheter 5FR
  • Karl Storz cystoscope 19-22F

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients undergoing planned procedure involving ureteroscopy or ureteral stenting
  • Abdominal CT scan performed within 6 months prior to intervention

Exclusion Criteria:

  • Known iodine sensitivity
  • Patients with fever or hemodynamic instability planned for urgent operation
  • Severe immune compromized patients
  • Severe thrombocytopenia < 50,000
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01542593


Locations
Israel
Carmel Medical Center
Haifa, Israel, 34362
Sponsors and Collaborators
Carmel Medical Center
Investigators
Principal Investigator: Yuval Freifeld, Dr. Carmel Medical Center
  More Information

Responsible Party: Yuval Freifeld, Resident , Urology Department, principal investigator, Medical doctor, Carmel Medical Center
ClinicalTrials.gov Identifier: NCT01542593     History of Changes
Other Study ID Numbers: CMC-11-0051-CTIL
First Submitted: February 16, 2012
First Posted: March 2, 2012
Last Update Posted: April 30, 2015
Last Verified: April 2015

Additional relevant MeSH terms:
Calculi
Hydronephrosis
Ureteral Obstruction
Ureteral Calculi
Ureterolithiasis
Pathological Conditions, Anatomical
Kidney Diseases
Urologic Diseases
Ureteral Diseases
Urolithiasis
Urinary Calculi